COVID-19 infection risk drops with increasing immunity within family
Oct 13, 2021
Risk for COVID-19 infection progressively lower for nonimmune family members as number of family members with immunity increases
Increase seen in years of life lost per COVID-19 death in 2021
Nov 29, 2022
Years of life lost increased 35.7% per COVID-19 death in 2021 versus 2020 as median age of COVID-19 deaths decreased.
Bipartisan bill aims to ensure safe volunteering for older adults during COVID-19 pandemic
By
Kimberly Bonvissuto
Jun 23, 2020
Two U.S. senators have introduced legislation to ensure that older adults can continue to volunteer during the COVID-19 pandemic.
Virologic rebound occurs in ~20 percent receiving nirmatrelvir-nitonavir
Nov 14, 2023
Virologic rebound was more common among those who started therapy within two days of symptom onset.
AHCA / NCAL, AMDA blast ‘short-sighted’ plans to discharge people with COVID-19 from hospitals to...
By
Lois A. Bowers
Mar 30, 2020
“The question all state officials must consider is whether the risk of introducing a virus with an estimated 30% or higher mortality rate into a nursing home or assisted living community outweighs...
Mortality risk increased for six months after COVID-19 in veterans
Aug 31, 2023
Those who survived COVID-19 had reduced mortality on days 181 to 365 and 366 to 730.
Sleep disturbance common after COVID-19 hospitalization
Apr 17, 2023
Associations were seen for overall sleep quality, deterioration in sleep quality after admission and sleep regularity with higher dyspnea scores.
Plasma viral antigen linked to baseline severity of COVID-19
Sep 07, 2022
High levels of plasma viral antigen are linked to outcomes such as worse pulmonary status and longer time to hospital discharge.
Metformin, ivermectin, fluvoxamine do not prevent severe COVID-19
Aug 19, 2022
No difference in the primary end point was seen with any of the three medications versus placebo among adults with overweight or obesity.
Seroprevalence to SARS-CoV-2 has increased over time
Nov 17, 2022
The global seroprevalence from infection or vaccination reached 59.2% by September 2021.